The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. 2008

Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
Department of Environmental Health and Center for Environmental Genetics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0056, USA.

Cellular stress by DNA damage induces checkpoint kinase-2 (CHK2)-mediated phosphorylation and stabilization of the E2F1 transcription factor, leading to induction of apoptosis by activation of a subset of proapoptotic E2F1 target genes, including Apaf1 and p73. This report characterizes an interaction between the aryl hydrocarbon (Ah) receptor (AHR), a ligand-activated transcription factor, and E2F1 that results in the attenuation of E2F1-mediated apoptosis. In Ahr(-/-) fibroblasts stably transfected with a doxycycline-regulated AHR expression vector, inhibition of AHR expression causes a significant elevation of oxidative stress, gammaH2A.X histone phosphorylation, and E2F1-dependent apoptosis, which can be blocked by small interfering RNA-mediated knockdown of E2F1 expression. In contrast, ligand-dependent AHR activation protects these cells from etoposide-induced cell death. In cells expressing both proteins, AHR and E2F1 interact independently of the retinoblastoma protein (RB), because AHR and E2F1 coimmunoprecipitate from extracts of RB-negative cells. Additionally, chromatin immunoprecipitation assays indicate that AHR and E2F1 bind to the Apaf1 promoter at a region containing a consensus E2F1 binding site but no AHR binding sites. AHR activation represses Apaf1 and TAp73 mRNA induction by a constitutively active CHK2 expression vector. Furthermore, AHR overexpression blocks the transcriptional induction of Apaf1 and p73 and the accumulation of sub-G(0)/G(1) cells resulting from ectopic overexpression of E2F1. These results point to a proproliferative, antiapoptotic function of the Ah receptor that likely plays a role in tumor progression.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D050687 E2F1 Transcription Factor An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A and activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F1 is involved in DNA REPAIR and APOPTOSIS. E2F Transcription Factor 1 Protein,E2F-1 Transcription Factor,Retinoblastoma Binding Protein 3,Retinoblastoma-Associated Protein 1,Transcription Factor E2F-1,Transcription Factor E2F1,Retinoblastoma Associated Protein 1,Transcription Factor E2F 1,Transcription Factor, E2F-1,Transcription Factor, E2F1

Related Publications

Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
March 2017, Biomolecules & therapeutics,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
January 2006, Molecular pharmacology,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
March 2005, Molecular pharmacology,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
April 2011, The American journal of pathology,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
May 2015, Pesticide biochemistry and physiology,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
September 2007, Biochemical and biophysical research communications,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
September 2000, Molecular pharmacology,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
January 1999, The Journal of biological chemistry,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
May 2021, Toxicology and applied pharmacology,
Jennifer L Marlowe, and Yunxia Fan, and Xiaoqing Chang, and Li Peng, and Erik S Knudsen, and Ying Xia, and Alvaro Puga
January 2010, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!